Medical Microbiology and Immunology

Papers
(The TQCC of Medical Microbiology and Immunology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Impaired detection of omicron by SARS-CoV-2 rapid antigen tests93
Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting65
The human symbiont Mucispirillum schaedleri: causality in health and disease65
Molecular mechanisms of dendritic cell migration in immunity and cancer53
Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern46
Influenza and RSV incidence during COVID-19 pandemic—an observational study from in-hospital point-of-care testing46
Head-to-head performance comparison of self-collected nasal versus professional-collected nasopharyngeal swab for a WHO-listed SARS-CoV-2 antigen-detecting rapid diagnostic test40
Bacterial aggregate size determines phagocytosis efficiency of polymorphonuclear leukocytes40
Tetraspanin CD53: an overlooked regulator of immune cell function39
Early changes in laboratory parameters are predictors of mortality and ICU admission in patients with COVID-19: a systematic review and meta-analysis37
Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings35
Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variants25
Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality20
Potential biomarkers of immune protection in human leishmaniasis19
Tetraspanin 7 and its closest paralog tetraspanin 6: membrane organizers with key functions in brain development, viral infection, innate immunity, diabetes and cancer19
Interferon antagonists encoded by SARS-CoV-2 at a glance19
Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admission18
Long non-coding RNA NEAT1 promotes lipopolysaccharide-induced injury in human tubule epithelial cells by regulating miR-93-5p/TXNIP axis18
Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity17
Tetraspanin CD9 affects HPV16 infection by modulating ADAM17 activity and the ERK signalling pathway16
An update: the emerging evidence of complement involvement in COVID-1914
Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity13
Cellular metabolic basis of altered immunity in the lungs of patients with COVID-1913
Functional cross-species conservation of guanylate-binding proteins in innate immunity12
What we actually know about the pathogenicity of Bacteroides pyogenes11
Tetraspanin CD81 regulates HSV-1 infection11
Tspan18 is a novel regulator of thrombo-inflammation11
HPV caught in the tetraspanin web?10
Tetraspanins in mammalian reproduction: spermatozoa, oocytes and embryos10
Mitochondria: intracellular sentinels of infections10
Tetraspanins in the regulation of mast cell function10
SARS-CoV-2 herd immunity of the Kyrgyz population in 202110
Outer inflammatory protein of Helicobacter pylori impacts IL-8 expression, adherence, cell apoptosis and cell cycle of gastric cells independent of its copy number10
Cytomegalovirus immune evasion sets the functional avidity threshold for protection by CD8 T cells10
Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy10
0.015547037124634